Spain· ES:58299
RIFATER COMPRIMIDOS RECUBIERTOS
A medicinal product containing rifampicina + isoniazida + pirazinamida, registered in Spain by Sanofi Aventis S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- rifampicina + isoniazida + pirazinamida
- Manufacturer
- Sanofi Aventis S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo988949100EUR 25.31
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifampicina + isoniazida + pirazinamida in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRifater tabletsDrugsrus Ltd
- NorwayRifaterSanofi-aventis
- FinlandRimcureSandoz A/S
- FranceRIFATER, comprimé enrobéSANOFI WINTHROP INDUSTRIE
- IrelandRifater 50 mg/300 mg/120 mg TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- SwitzerlandRifater, comprimés enrobésSanofi-Aventis (Suisse) SA
- SwedenRimcure 150 mg/75 mg/400 mg Filmdragerad tablettSandoz A/S
- CzechiaRIFAMPICIN 75MG + ISONIAZID 50MG + PYRAZINAMIDE 150MG
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- France · Rifater
- United Kingdom (Northern Ireland) · Rifater
- Ireland · Rifater
- Italy · Rifater
- Norway · Rimcure
- Portugal · Rifater
- Sweden · Rimcure
- Slovenia · Rifater
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56fb82c8-cd48-4fc6-b8e4-112134c3d005 GET /v1/drugs/56fb82c8-cd48-4fc6-b8e4-112134c3d005?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":607384800000}",
"nregistro": "58299",
"substance": "rifampicina + isoniazida + pirazinamida"
}See everything about rifampicina + isoniazida + pirazinamida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.